JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$5.77B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$5.31B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.14B |
| 4 |
Meta Platforms (Facebook)
META
|
+$2.76B |
| 5 |
Apple
AAPL
|
+$2.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.22B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.77B |
| 3 |
Nike
NKE
|
+$744M |
| 4 |
Schwab US TIPS ETF
SCHP
|
+$710M |
| 5 |
Truist Financial
TFC
|
+$605M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.48% |
| 2 | Healthcare | 10.48% |
| 3 | Financials | 8.96% |
| 4 | Consumer Discretionary | 8.42% |
| 5 | Industrials | 7.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
TORM
TRMD
$3.05B
| $16.3M | ﹤0.01% |
675,789
-475,830
| -41% | -$13.2M |
|
1802
Sixth Street Specialty
TSLX
$1.67B
| $16.3M | ﹤0.01% |
873,489
+647,808
| +287% | +$11.8M |
|
1803
Onto Innovation
ONTO
$10.9B
| $16.3M | ﹤0.01% |
140,091
+31,167
| +29% | +$2.97M |
|
1804
Avantor
AVTR
$9.73B
| $16.3M | ﹤0.01% |
793,679
+156,820
| +25% | +$3.17M |
|
|
MDRX
1805
DELISTED
Veradigm Inc. Common Stock
MDRX
| $16.3M | ﹤0.01% |
1,292,209
+274,053
| +27% | +$3.33M |
|
|
IMGN
1806
DELISTED
Immunogen Inc
IMGN
| $16.3M | ﹤0.01% |
862,422
-106,311
| -11% | -$1.26M |
|
1807
PUT
SLB Ltd
SLB
$72.7B
| $16.2M | ﹤0.01% |
330,700
+161,700
| +96% | +$7.71M |
|
1808
CALL
Wayfair
W
$11.8B
| $16.2M | ﹤0.01% |
249,600
| – | – |
|
1809
Rocket Pharmaceuticals
RCKT
$343M
| $16.2M | ﹤0.01% |
816,294
-4,981
| -0.6% | -$101K |
|
1810
Syndax Pharmaceuticals
SNDX
$1.7B
| $16.1M | ﹤0.01% |
770,721
+221,636
| +40% | +$4.61M |
|
1811
Trex
TREX
$4.4B
| $16.1M | ﹤0.01% |
245,823
+19,611
| +9% | +$1.09M |
|
1812
Extreme Networks
EXTR
$3.8B
| $16.1M | ﹤0.01% |
618,444
-18,595
| -3% | -$367K |
|
1813
PUT
Hewlett Packard
HPE
$58.8B
| $16M | ﹤0.01% |
954,800
+159,000
| +20% | +$2.43M |
|
1814
Amkor Technology
AMKR
$10.6B
| $16M | ﹤0.01% |
538,864
+187,685
| +53% | +$4.57M |
|
1815
Brookfield Renewable
BEPC
$5.86B
| $16M | ﹤0.01% |
507,207
+2,102
| +0.4% | +$70.9K |
|
1816
CVB Financial
CVBF
$4.02B
| $16M | ﹤0.01% |
1,203,612
-163,400
| -12% | -$2.25M |
|
1817
Haemonetics
HAE
$3.88B
| $16M | ﹤0.01% |
187,678
+9,787
| +6% | +$827K |
|
1818
MSC Industrial Direct
MSM
$6.76B
| $15.9M | ﹤0.01% |
167,287
+18,640
| +13% | +$1.71M |
|
1819
WisdomTree Japan Hedged Equity Fund
DXJ
$7.07B
| $15.9M | ﹤0.01% |
190,961
-77,016
| -29% | -$5.86M |
|
1820
CALL
Nu Holdings
NU
$67.8B
| $15.9M | ﹤0.01% |
+2,012,300
| New | +$12.4M |
|
1821
CALL
AB InBev
BUD
$164B
| $15.9M | ﹤0.01% |
279,700
+279,400
| +93,133% | +$16.9M |
|
|
ISEE
1822
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $15.9M | ﹤0.01% |
403,077
-379,019
| -48% | -$13.4M |
|
1823
Merchants Bancorp
MBIN
$2.49B
| $15.8M | ﹤0.01% |
619,112
+106,954
| +21% | +$2.65M |
|
1824
Construction Partners
ROAD
$5.88B
| $15.8M | ﹤0.01% |
504,372
+410,306
| +436% | +$11.7M |
|
1825
Suburban Propane Partners
SPH
$1.21B
| $15.8M | ﹤0.01% |
1,069,689
-25,612
| -2% | -$387K |
|
Similar funds
JP Morgan Chase's Q2 2023 Portfolio in Review
As of Q2 2023, JP Morgan Chase held 7,602 positions worth $920B, up 12% from $821B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
JP Morgan Chase deployed $40.5B of net new capital in Q2 2023, opening 674 new positions and adding to 3,069 existing holdings. Its largest new stake was JPMorgan BetaBuilders Emerging Markets Equity ETF: 10,009,525 shares worth $488M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares 0-1 Year Treasury Bond ETF, an estimated $3.22B trimmed.
- JP Morgan Chase's largest Q2 2023 buy was JPMorgan BetaBuilders Emerging Markets Equity ETF: 10,009,525 shares worth $488M.
- JP Morgan Chase added most to Microsoft in Q2 2023, an estimated $5.77B increase.
- JP Morgan Chase's biggest Q2 2023 reduction was iShares 0-1 Year Treasury Bond ETF, cutting an estimated $3.22B.
- JP Morgan Chase fully exited DCP Midstream, LP in Q2 2023, selling an estimated $328M.
- JP Morgan Chase's ten largest holdings make up 20% of its $920B portfolio in Q2 2023.
- JP Morgan Chase opened 674 new positions and closed 737 in Q2 2023.
- JP Morgan Chase's portfolio value rose 12% quarter-over-quarter to $920B.
Based on JP Morgan Chase's 13F filing for Q2 2023, filed 11 Aug 2023.